Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/30031
Title: Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.
Authors: 
Goode, Ellen L
Block, Matthew S
Kalli, Kimberly R
Vierkant, Robert A
Chen, Wenqian
Fogarty, Zachary C
Gentry-Maharaj, Aleksandra
Tołoczko, Aleksandra
Hein, Alexander
Bouligny, Aliecia L
Jensen, Allan
Osorio, Ana
Hartkopf, Andreas
Ryan, Andy
Chudecka-Głaz, Anita
Magliocco, Anthony M
Hartmann, Arndt
Jung, Audrey Y
Gao, Bo
Hernandez, Brenda Y
Fridley, Brooke L
McCauley, Bryan M
Kennedy, Catherine J
Wang, Chen
Karpinskyj, Chloe
de Sousa, Christiani B
Tiezzi, Daniel G
Wachter, David L
Herpel, Esther
Taran, Florin Andrei
Modugno, Francesmary
Nelson, Gregg
Lubiński, Jan
Menkiszak, Janusz
Alsop, Jennifer
Lester, Jenny
García-Donas, Jesús
Nation, Jill
Hung, Jillian
Palacios, José
Rothstein, Joseph H
Kelley, Joseph L
de Andrade, Jurandyr M
Robles-Díaz, Luis
Intermaggio, Maria P
Widschwendter, Martin
Beckmann, Matthias W
Ruebner, Matthias
Jimenez-Linan, Mercedes
Singh, Naveena
Oszurek, Oleg
Harnett, Paul R
Rambau, Peter F
Sinn, Peter
Wagner, Philipp
Ghatage, Prafull
Sharma, Raghwa
Edwards, Robert P
Ness, Roberta B
Orsulic, Sandra
Brucker, Sara Y
Johnatty, Sharon E
Longacre, Teri A
Ursula, Eilber
McGuire, Valerie
Sieh, Weiva
Natanzon, Yanina
Li, Zheng
Whittemore, Alice S
Anna, deFazio
Staebler, Annette
Karlan, Beth Y
Gilks, Blake
Bowtell, David D
Høgdall, Estrid
Candido dos Reis, Francisco J
Steed, Helen
Campbell, Ian G
Gronwald, Jacek
Benítez, Javier
Koziak, Jennifer M
Chang-Claude, Jenny
Moysich, Kirsten B
Kelemen, Linda E
Cook, Linda S
Goodman, Marc T
García, María José
Fasching, Peter A
Kommoss, Stefan
Deen, Suha
Kjaer, Susanne K
Menon, Usha
Brenton, James D
Pharoah, Paul DP
Chenevix-Trench, Georgia
Huntsman, David G
Winham, Stacey J
Köbel, Martin
Ramus, Susan J
Mesh: 
Issue Date: 2017
Citation: JAMA Oncol.2017 12;(3)12:e173290
Abstract: Cytotoxic CD8+ tumor-infiltrating lymphocytes (TILs) participate in immune control of epithelial ovarian cancer; however, little is known about prognostic patterns of CD8+ TILs by histotype and in relation to other clinical factors.
PMID: 29049607
URI: https://hdl.handle.net/20.500.12530/30031
Rights: openAccess
Appears in Collections:Hospitales > H. U. 12 de Octubre > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. 12 de Octubre > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC5744673.pdf213.54 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.